iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Acquired by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC increased its stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 132,602 shares of the company’s stock after purchasing an additional 2,742 shares during the quarter. Segall Bryant & Hamill LLC owned 0.42% of iRhythm Technologies worth $9,844,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC lifted its stake in shares of iRhythm Technologies by 79.6% in the 2nd quarter. Nisa Investment Advisors LLC now owns 625 shares of the company’s stock worth $67,000 after acquiring an additional 277 shares during the period. SG Americas Securities LLC acquired a new stake in iRhythm Technologies in the first quarter valued at about $126,000. nVerses Capital LLC boosted its holdings in iRhythm Technologies by 400.0% in the 3rd quarter. nVerses Capital LLC now owns 2,000 shares of the company’s stock valued at $148,000 after purchasing an additional 1,600 shares in the last quarter. Russell Investments Group Ltd. increased its position in iRhythm Technologies by 79,700.0% during the 1st quarter. Russell Investments Group Ltd. now owns 1,596 shares of the company’s stock worth $185,000 after purchasing an additional 1,594 shares during the period. Finally, SeaCrest Wealth Management LLC lifted its holdings in shares of iRhythm Technologies by 7.6% in the 2nd quarter. SeaCrest Wealth Management LLC now owns 2,125 shares of the company’s stock valued at $229,000 after buying an additional 150 shares during the period.

Analysts Set New Price Targets

Several research analysts have issued reports on IRTC shares. Truist Financial increased their price objective on iRhythm Technologies from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. StockNews.com downgraded shares of iRhythm Technologies from a “hold” rating to a “sell” rating in a report on Friday, September 27th. Canaccord Genuity Group increased their target price on shares of iRhythm Technologies from $122.00 to $137.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Needham & Company LLC decreased their price target on iRhythm Technologies from $119.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, October 31st. Finally, Citigroup lowered their price target on iRhythm Technologies from $135.00 to $110.00 and set a “buy” rating on the stock in a report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $108.50.

iRhythm Technologies Stock Up 0.7 %

IRTC opened at $74.24 on Friday. The business’s fifty day simple moving average is $72.81 and its 200 day simple moving average is $82.45. iRhythm Technologies, Inc. has a 52 week low of $55.92 and a 52 week high of $124.11. The firm has a market cap of $2.32 billion, a P/E ratio of -15.27 and a beta of 1.23. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00.

iRhythm Technologies (NASDAQ:IRTC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported ($1.26) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.71). The firm had revenue of $147.54 million for the quarter, compared to analysts’ expectations of $146.69 million. iRhythm Technologies had a negative return on equity of 120.86% and a negative net margin of 26.90%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.89) earnings per share. As a group, equities research analysts anticipate that iRhythm Technologies, Inc. will post -3.44 EPS for the current fiscal year.

Insider Transactions at iRhythm Technologies

In related news, CEO Quentin S. Blackford sold 16,145 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $77.41, for a total value of $1,249,784.45. Following the completion of the sale, the chief executive officer now directly owns 159,929 shares in the company, valued at approximately $12,380,103.89. The trade was a 9.17 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Abhijit Y. Talwalkar purchased 6,664 shares of the business’s stock in a transaction on Monday, November 4th. The shares were bought at an average cost of $75.16 per share, for a total transaction of $500,866.24. Following the purchase, the director now owns 18,941 shares of the company’s stock, valued at $1,423,605.56. This trade represents a 54.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.68% of the company’s stock.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.